NCT06765707View on ClinicalTrials.gov

Symptom Monitoring Using Patient-Report to Improve Medication Use

NAEnrolling by invitationINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

August 31, 2029

Conditions
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Endocrine Therapy
Interventions
BEHAVIORAL

Pharmacist delivered symptom monitoring and management

Patients in the intervention phase will receive PRO-based symptom monitoring once a month and pharmacist-led management for problematic symptoms based on routine clinical care recommendations.

Trial Locations (3)

26509

Medical College of Wisconsin, Milwaukee

55905

Mayo Clinic, Rochester

60612

University of Illinois Chicago, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Medical College of Wisconsin

OTHER